Newsroom2021-01-13T08:26:53-05:00

Newsroom – Important Announcements and Information Regarding Cosette Pharma

4Mar. 2021

Cosette Pharmaceuticals, Inc. Announces FDA Approval of ANDA for Hydrocortisone Valerate Cream USP, 0.2%

Bridgewater, NJ (March 04, 2021) – Cosette Pharmaceuticals, Inc., a New Jersey-based specialty generic pharmaceutical company, has received a first cycle approval of the Company’s abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration (FDA) of Hydrocortisone Valerate Cream USP, 0.2%. This is Cosette’s first approval for 2021 from its internally-developed pipeline of prescription pharmaceutical products. “I am excited about our most recent approval,’’ commented Apurva Saraf, President and CEO of the Company. “This approval is further validation of Cosette’s R&D and regulatory capabilities to develop, file and receive approvals for complex products. We remain relentlessly focused on developing and launching these essential and  affordable medicines for the patients we serve.” Mr. Saraf continued, “We now have 42 pharmaceutical [...]

14Jul. 2020

Cosette Pharmaceuticals Appoints Seasoned Industry Executive Apurva Saraf as President and Chief Executive Officer

Bridgewater, NJ (July 14, 2020) – “We are very pleased to welcome Apurva to the Cosette team. His deep knowledge of the pharmaceutical industry, along with his corporate strategy and business development experience, will be of great value as Cosette continues to expand its portfolio of differentiated complex products, both internally and through strategic collaborations,” stated Sriram Venkataraman, Partner of Avista Capital Partners. “We are proud of Cosette’s unique corporate culture, consumer-centric focus, and emphasis on high-quality products and believe that Apurva will be the ideal leader to drive the next phase of the Company’s growth,” concluded Venkataraman. “I am excited for the opportunity to contribute to Cosette’s growth and build upon its impressive portfolio of products. I look [...]

3Jul. 2020

Donation to First Baptist Children’s Ministry

Bridgewater, NJ (July 3, 2020) – As a means of preventing the spread of Covid-19, Cosette Pharmaceuticals has donated bottles of hand sanitizers to First Baptist Children’s Ministry in order to keep students and teachers safe while at the center. About Cosette Pharmaceuticals, Inc. Cosette Pharmaceuticals, Inc. is a generic pharmaceutical company specializing in the areas of dermatology and allergy, with products available in dosage forms such as creams, ointments, lotions, solutions, gels, pastes and suppositories. The company was formed when Avista Capital Partners, a leading private equity firm focused on growth-oriented healthcare businesses, purchased the extended topicals and dermatology portfolio of G&W Laboratories in December 2018.  Cosette is expanding its product offering by bringing new products to market [...]

20Jun. 2020

The Impact of Giving

Bridgewater, NJ (June 20, 2020) – Just months after launching the COVID-19 Support Fund for Morristown Medical Center, community members — gave more than $3 million to purchase much-needed equipment for critical care patients, Donations also included personal protective equipment (PPE) – in bulk and individual, homemade masks – and vital medical supplies, as well as staff meals, which are still pouring into the hospital every day. Cosette Pharmaceuticals as a kind gift distributed 5,000 Units of hand sanitizers. Published at https://f4mmc.org/1-Million-for-Morristown.aspx About Cosette Pharmaceuticals, Inc. Cosette Pharmaceuticals, Inc. is a generic pharmaceutical company specializing in the areas of dermatology and allergy, with products available in dosage forms such as creams, ointments, lotions, solutions, gels, pastes and suppositories. The [...]

20May. 2020

Cosette manufactures and donates hand sanitizers

Bridgewater, NJ (May 20, 2020) – COVID-19 outbreak has created a severe shortage of hand sanitizer essential for the hygiene of everyone; especially, for patients, their friends & family and the healthcare professionals treating them. In response and as part of our commitment to deliver products to people and patients in need, Cosette announced that it is realigning its South Plainfield manufacturing and distribution resources to meet this heightened demand by donating hand sanitizers produced by Cosette within our communities and hospitals. As soon as Cosette learned about the shortage, a project team quickly came together to step up, collaborate and offer help and meet its continuing social responsibility. About Cosette Pharmaceuticals, Inc. Cosette Pharmaceuticals, Inc. is a generic [...]

1Nov. 2019

Cosette Pharmaceuticals Announces the Launch of Migergot® (Ergotamine Tartrate and Caffeine Suppositories)

Bridgewater, NJ (November 1, 2019) – Cosette Pharmaceuticals, Inc., a generic pharmaceutical company primarily focused on extended topical and suppository products, announced today that it will be commercializing Migergot® (ergotamine tartrate and caffeine suppositories) for the US market and will continue its role as the manufacturer. “We are very pleased to be launching Migergot® for several important reasons,” said Walt Kaczmarek, President and Chief Executive Officer of Cosette.  “First, it marks an important milestone as the first product in our portfolio to be marketed in a Cosette label to customers and patients.  Second, it demonstrates our continued commitment to enhancing the Cosette product line with products where we can leverage our expertise in suppositories and other differentiated dosage forms.” Migergot® is indicated [...]